The World Market for Diabetes Treatments Now Available at ReportsandReports

By Marketsandmarkets, PRNE
Wednesday, October 13, 2010

ReportsandReports Announces it Will Carry The World Market for Diabetes Treatments Research Report in its Store

DALLAS, October 14, 2010 - Browse the complete Report on:
www.reportsandreports.com/reports/35297-the-world-market-for-diabetes-
treatments.html

This Kalorama Information report , The World Market for Diabetes
Treatments, provides market estimates and forecasts for the world market for
diabetes treatments. The diabetes market is one of the fastest growing
markets within the pharmaceutical sector, and is one of the few
pharmaceutical sectors that is likely to continue to grow at double digit
rates throughout the forecast period. Major contributing factors to growth
are increasing obesity and an aging worldwide population. The total market
for diabetes treatments is divided into two major segments:

    - Insulin Markets in US, Europe, Japan, ROW
    - Oral Hypoglycemics in US, Europe, Japan, ROW

For each of these market segments the report provides market share and
regional breakout (US, Europe, Asia, ROW). The report also discusses
treatment for diabetes complications and natural and herbal treatments.

The report's geographic scope is worldwide with information for specific
geographical regions; world demographics; life expectancy by country, and
other general issues affecting the market. Trends covered in the report
include:

    - New Products and the Development Pipeline (Afrezza, Bydureon,
      Syncria, AVE0010, Balaglitazone, Metgluna Otelixizumab and others)
    - Transplantation Research Efforts
    - B-Cell Transplantation Research
    - Potential New Drug for Type 2 Diabetes
    - Insulin Pills
    - Three-month Insulin Shot
    - Outsourcing of Diabetes Projects
    - Reclassification of Cause of Death

Information is presented as a worldwide overview, with special emphasis
on the U.S., Europe, and other key markets.

A market summary includes market analysis by product and region and a
competitive analysis of leading providers. Additionally, key company profiles
are included, including profiles of the following:

    - Amylin Pharmaceuticals
    - AstraZeneca
    - GlaxoSmithKline
    - Eli Lilly & Co.
    - Merck
    - Metabolex, Inc.
    - Novo Nordisk A/S
    - Pfizer Inc.
    - Sanofi-Aventis Group
    - Takeda Pharmaceutical Company Limited

The information for this report was gathered using both primary and
secondary research including comprehensive research of secondary sources such
as company literature, databases, investment reports, and medical and
business journals. Telephone interviews and email correspondence were the
primary method of gathering information.

For the purpose of this study, Kalorama Information conducted interviews
with more than 25 key industry officials, consultants, health care providers,
and government personnel. These sources were the primary basis in gathering
information specifically relating to revenue and market share data presented
in this report. Additional interviews were completed with relevant company
representatives including marketing directors, division managers, and product
representatives.

www.reportsandreports.com/reports/35298-infusion-pump-markets-larg
e-volume-ambulatory-insulin-enteral.html

www.reportsandreports.com/reports/35299-water-and-air-purification
-systems-and-products-residential-co.html

www.reportsandreports.com/reports/35300-global-smart-grid-enabling
-products-market.html

(Due to the length of these URLs, it may be necessary to copy and paste
this hyperlink into your Internet browser's URL address field. Remove the
space if one exists.)

All market data pertains to the world market at the manufacturers' level.
The base year for data was 2009. Historical data was provided for the years
2008, with forecast data provided for 2010 through 2015. Compound annual
growth rates (CAGRs) are provided for 2008-2015 periods for each region
and/or segment covered. Competitive analysis is provided for the year 2009.
The forecasted market analysis for 2009-2015 was largely based on demographic
trends, new developments, innovative technology and global expansion.

Browse all Healthcare Reports at
www.reportsandreports.com/cat/healthcare-market-research.html

Browse All Specific Markets:
www.reportsandreports.com/tagIndex.aspx

Browse All Country Reports:
www.reportsandreports.com/countryIndex.aspx

Browse All Cancer Vaccine Reports:
www.reportsandreports.com/tags/diabetes-market-research.html

About Us

ReportsandReports comprises an online library of 10,000 reports, in-depth
market research studies of over 5000 micro markets, and 25 industry specific
websites. Our client list boasts almost all well-known publishers of such
reports across the globe. We as a third-party reseller of market research
reports employ a number of marketing tools, such as press releases,
email-marketing and effective search-engine optimization techniques to drive
revenues for our clients. We also provide 24/7 online and offline support
service to our customers.

    Contact:
    Ms. Sunita
    7557 Rambler road,
    Suite 727, Dallas, TX 75231
    Tel: +1-888-989-8004

reportsandreports.blogspot.com/

reportsandreports.proarticles.co.uk/

reportsnreports.wordpress.com/

Contact: Ms. Sunita, 7557 Rambler road, Suite 727, Dallas, TX 75231, Tel: +1-888-989-8004

Biotechnology News

October 14 News

YOUR VIEW POINT
NAME : (REQUIRED)
MAIL : (REQUIRED)
will not be displayed
WEBSITE : (OPTIONAL)
YOUR
COMMENT :